1. Mitochondria-Targeting Click-Derived Pyridinyltriazolylmethylquinoxaline-Based Y- Shaped Binuclear Luminescent Ruthenium (II) and Iridium (III) Complexes as Cancer Theranostics.

      Roy, N., Sen, U., Madaan, Y., Muthukumar, V., Varddhan, S., Sahoo, S.K., Paira, P.

      Inorganic Chemistry, 2020,59 (23), 17689-17711.






 

   2. Hypoxia-efficient and glutathione-resistant cytoselective ruthenium (II)-p-cymene- arylimidazophenanthroline complexes: biomolecular interaction cell imaging.

      Mondal, A., Paira, P.

      Dalton Transactions, 2020, 49 (36), 12865-12878.






 

   3. Cu (ii), Ir (i) and CuO nanocatalyzed mild synthesis luminescent symmetrical and unsymmetrical bis (triazolylmethyl) quinoxalines: biocompatibility, cytotoxicity,live cell.

       Maiti, S., Roy, N., Babu, L.T., Moharana, P., Athira, C.C., Sreedhar, E.D., De, S., Paira, P.

       New Journal of Chemistry,2020, 44 (3), 920-931.






 

   4. Luminescent anticancer Ru (II)-arenebipyridine and phenanthroline complexes: Synthesis, characterization, DFT studies, biological interactions and cellular imaging application.

       Anuja, P.K., Paira, P.

      Journal of Inorganic Biochemistry, 2020, 208, 111099.






 

   5.Green synthesis highly luminescent biotin-conjugated CdSe quantum dots for bioimaging applications.

      Roy, N., Moharana, P., Ghosh, K., Paira, P.

      New Journal of Chemistry 2020, 44 (39), 16891-16899.







 

   6. Inhibition glioblastoma and macrophage phagocytosis using sialic acid-grafted tamoxifen-carmustine-polyethyleneimine-poly (lactic-co-glycolic acid) nanoparticles.

       Kuo, Y.C., Rajesh, R., Yen, M.H., Paira, P.

       Journal of the Taiwan Institute of Chemical Engineers, 2020, 111, 302-311.






 

   7. Combined palladium/eosin Y-catalysed direct synthesis anticancer biarylquinolinooxazocino-quinoxaline-1-ones under visible light one-pot sequence:a revisited proof of concept.

       Roy, N., Paira, P.

       Monatshefte für Chemie-Chemical Monthly, 2020, 151 (7), 1163-1172.






.

   8. Recent Advances Cytotoxicity, Cellular Uptake and Mechanism Action of Ruthenium metallodrugs: A Review.

       Sudhindra, P., Sharma, S.A., Roy, N., Moharana, P., Paira, P.

       Polyhedron, 2020, 114827.






 

  9. Advances novel iridium (III) based complexes for anticancer applications: a review.

        Sharma, S.A., Sudhindra, P., Roy, N., Paira, P.

        Inorganica Chimica Acta, 2020, 119925.






 

  10. Ruthenium and Iridium-based mononuclear and multinuclear complexes: A Breakthrough of Next-Generation Anticancer Metallo pharmaceuticals.

        Kar, B., Roy, N., Sudhindra, P., Moharana, P., Paira, P.

        Inorganica Chimica Acta, 2020, 119858.